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Osteoarthritis (OA) is a widespread musculoskeletal disease that reduces quality of life and for which
there is no cure. The treatment of OA is challenging since cartilage impedes the local and systemic de-
livery of therapeutic compounds (TCs). This review identiﬁes high-intensity ultrasound (HIU) as a non-
contact technique to modify articular cartilage and subchondral bone. HIU enables new approaches to
overcome challenges associated with drug delivery to cartilage and new non-invasive approaches for the
treatment of joint disease. Speciﬁcally, HIU has the potential to facilitate targeted drug delivery and
release deep within cartilage, to repair soft tissue damage, and to physically alter tissue structures
including cartilage and bone. The localized, non-invasive ultrasonic delivery of TCs to articular cartilage
and subchondral bone appears to be a promising technique in the immediate future.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Articular cartilage covers the surfaces of synovial joints where it
prevents direct bone to-bone contact and enables pain-free artic-
ulation of the joint. Osteoarthritis (OA) is a degenerative disease
that affects the joints and surrounding tissues. Radiographically, OA
is commonly described as a loss or thinning of cartilage at the
articulating surfaces of long bones. However, the process of carti-
lage degeneration also includes changes in the joint structure and
surrounding tissues. Symptomatic patients with OA often experi-
ence joint pain, stiffness, and a loss of joint mobility1. The devel-
opment of OA involves distinct morphological changes2, depending
on the extent of degeneration. Trauma, or more speciﬁcally me-
chanical damage to the cartilage, can also induce degradation and
OA3e5.
All cartilage-covered joints are susceptible to OA and there is
no cure for this disease. OA is a global problem that reduces
quality of life and results in signiﬁcant economic impact6,7.S.A. Hacking, Laboratory for
nt of Orthopaedics, Harvard
l, 55 Fruit St, Rm. GRJ 1120,
3.
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ternational. Published by Elsevier LWorldwide, 9.6% of men and 18% of women over 60 years suffer
from symptomatic OA and the disease is expected to be the fourth
leading cause of disability by 20208. Post-traumatic OA, accounts
12% of all OA9, as young as 30 years of age can lead to symp-
tomatic OA10. Because of OA's wide-reaching implications, there is
a persistent interest in developing new approaches to prevent,
retard, halt or potentially reverse the progression of OA11e13.
Currently, the most successful treatment for advanced OA is to
replace articulating surfaces with mechanical components in a
procedure known as total joint arthroplasty (TJA)14,15. While
successful, the need for TJA may be delayed by more efﬁcient
disease-modifying treatments for OA, which would be the
preferred option in especially young knee injury patients likely to
develop OA10.Background
Unique properties of osteochondral tissue
In individuals with healthy joints, articular cartilage forms a low
friction surface about 1e3 mm thick. As a material, cartilage is a
ﬁber-reinforced hydrogel with tortuous nano-sized pores [Fig. 1].
More speciﬁcally, cartilage is a ﬁbril-reinforced poroviscoelastic
cushion16 that retains liquid during fast loading while permitting
liquid ﬂow during static loading17. The unique and dynamic ma-
terial properties of cartilage result from its structure andtd. All rights reserved.
High-intensity ultrasound terminology
Absorption loss of acoustic energy converted into other forms of energy such as heat.
Acoustic discontinuity spatially abrupt change in e.g., speed of sound or acoustic impedance at an interface between two
materials.
Acoustic impedance material property that describes how much pressure is generated in a medium from spatial
displacement of its molecules at a given frequency. Sound is reﬂected at an interface between two
materials with different acoustic impedances.
Acoustic radiation force force induced by sound impinging on sound-absorbing material (e.g., tissue) or acoustic interfaces
(e.g., ﬂuidetissue or gaseﬂuid interface).
ARFI, i.e., Acoustic Radiation
Force Impulse imaging
an elasticity imaging technique in which acoustic radiation force produces spatial tissue
displacement, which is recorded by ultrasound imaging device. The detected spatial displacement
are converted into spatial elasticity images that can be used to diagnose e.g., hard tumors deep in the
body that are difﬁcult to palpate.
Acoustic streaming streaming of ﬂuids induced by absorption of sound into the medium.
Attenuation loss of acoustic energy due to absorption, sound scattering at acoustic discontinuities and spreading of
the sound beam (geometric attenuation).
Cavitation (stable, inertial) interaction of acoustic pressure variation and gas micro-bubbles leading to radial bubble oscillation
(stable cavitation). This can induce ﬂuid streams around the bubble and shear forces on cells.
Combining intense sound and micro-bubbles allows producing micro-implosions or fast and hot
water-jets at the micro-scale that can micro-machine material (inertial cavitation). Cavitation is a
threshold phenomenon that can be controlled by adjusting frequency, maximum negative sound
pressure amplitude, and duration of the applied sound pulse.
Displacement in ultrasound wave, molecules oscillate coherently around their rest position. The distance of
molecules from their rest position is called a displacement. In longitudinal or shear waves the
displacement of molecules occur along or perpendicular to the direction of ultrasound propagation,
respectively.
HIU high-intensity ultrasound or power ultrasound has 1 W/cm2 intensity.
HIFU, i.e., High-Intensity
Focused Ultrasound
High-Intensity Focused Ultrasound is HIU that is produced by geometrically and/or electrically
focusing ultrasound energy into a small volume. In medicine, HIFU is typically used to thermally
ablate tumor tissue.
Intensity power of sound per unit area perpendicular to the direction of ultrasound propagation (SI unit: W/
cm2). Ultrasound intensity is directly proportional to the square of ultrasound pressure.
Lithoptripsy method for breaking gallstones or other calculi by strong shock waves.
LIU low-intensity ultrasound or low power ultrasound has (1 W/cm2 intensity.
Longitudinal wave see displacement.
Micro-bubble a micron sized gas bubble. When a micro-bubble interacts with sound, a phenomenon called
cavitation may occur. Micro-bubbles are used in medicine as ultrasound imaging contrast agents
(enhanced scattering of sound) and in therapy applications (enhanced cavitation effects). Nano-
bubbles have shown promise to act as ultrasound contrast agents.
PRF, i.e., pulse repetition
frequency
the rate (Hz) at which ultrasound pulses or bursts is generated.
Pressure ultrasonic pressure appears as a traveling density disturbance of material oscillating at a frequency
>20 kHz.
Reﬂection reﬂection of sound occurs when sound meets an acoustic impedance mismatch (see acoustic
discontinuity), which is greater in size than the wavelength (e.g., collagen bundle). When the
discontinuity is of same size or smaller than the wavelength of the sound wave, scattering occurs
instead of reﬂection. Collagen at superﬁcial articular cartilage or inside cartilage is known to be a
strong reﬂector or scatterer of ultrasound, respectively.
Scattering see reﬂection.
Shear wave see displacement.
Speed of sound a property of a sound wave describing the traveling speed of a wave. In articular cartilage, the
ultrasound speed is typically 1600e1700 m/s in MHz domain.
Shock wave a traveling acoustic wave with steep temporal and spatial gradients in pressure. This is typically a
short impulse-like acoustic wave with high pressure amplitude and broadband spectral content. Its
propagation speed depends on intensity.
Thermal ablation removal of tissue by heat. This strategy is used e.g., in HIFU surgery, where tumor cells are killed by
heating tissue with focused ultrasound.
Ultrasonic actuation a process of using ultrasound to modify, machine or micro-machinematerial such as tissue. Common
examples of ultrasound actuation are: cutting: ultrasonic knife with vibrating blade to enhance
surgical cutting of tissues. e homogenization: ultrasound can be used to homogenize tissue by
typically combining low-frequency ultrasound with strong inertial cavitation. e milling, abrading or
polishing: in these industrial actuation techniques high-intensity ultrasound is applied to milling,
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abrading or polishing tools to enhance the desired actuation effect. e translation: acoustic radiation
force can move tissue or translate gas within a ﬂuid. e heating: ultrasound can be used to selectively
heat tissue for thermal ablation or hyperthermia.ewelding: applying ultrasound to the bonding spot
during a welding process, e.g., a stronger bond can be achieved. e tearing: stresses from shock waves
can tear molecule bonds and consequently tear materials such as tissue. e hardening or softening:
ultrasound can harden or soften some engineering materials.
Ultrasound coherent spatial oscillation of atoms exceeding the spectral range of human hearing
(frequencies > 20 kHz) resulting in a traveling (or standing) waveform. Spatial oscillation of
molecules results in density and pressure oscillation of the material.
Ultrasound speed see speed of sound.
Wavelength the length (m) of one sinusoidal oscillation of a wave. In articular cartilage, the wavelengths of
100 kHz, 1 MHz and 10 MHz ultrasound are about 16 mm, 1.6 mm and 160 mm.
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proteins (collagen and proteoglycans), and chondrocytes
[Fig. 1]14,18. Aggrecan proteoglycans are large brush-shaped nega-
tively charged macromolecules that interact with and limit the
movement of water and other molecules within cartilage19. While
this unique biochemical environment is essential for cartilage
function20, it is an impediment to the delivery of therapeutic
compounds (TCs)21.
Challenges facing cartilage repair
At the most basic level, tissue repair requires cells and meta-
bolic support provided by vascularity. The repair of articular
cartilage is particularly challenging since the tissue has few native
cells and no blood supply [Fig. 1]14. Studies in vitro and in animals
suggest that the repair of cartilage may be enhanced by several
TCs including growth factors4,22, cytokine blockers4,22,23, cortico-
steroids24, and protease inhibitors4,22. It is generally accepted that
these molecules alter matrix degradation and/or contribute to cell
activity or recruitment to aid tissue repair. While promising, the
delivery of such factors that can enhance the native reparative
potential of this tissue remains challenging18, and none of these
TCs are currently approved as disease modifying osteoarthritic
drugs (DMOADs)4,25.Fig. 1. Schematic representation of the structure and composition of articular cartilage. Artic
the ends of synovial joints. Cartilage is comprised of complex gradients in cell density, prote
tissue depth. The lack of vasculature and high proteoglycan content limits the effectiveness
into the tissue.There are two major obstacles impeding the application of TCs
for cartilage repair. First, the systemic delivery of TCs to cartilage is
difﬁcult since cartilage is typically avascular and second, the
biochemical composition of cartilage restricts the diffusion of
large molecules19,26. This explains why the direct injection of TCs
with large molecules into the joint space27 may seem promising
conceptually, but as a result of their limited diffusion into cartilage
any therapeutic potential is greatly reduced. In contrast, TCs of
sufﬁciently small size can diffuse into cartilage from the synovial
ﬂuid, but are also prone to short periods of residence (i.e., wash-out
in time scale of hours) that also reduce TC's therapeutic beneﬁt28,29.
While the average pore size inside cartilage that is available for
ﬂuid ﬂow is 6 nm20, delivery of molecules as large as 7e10 nm has
been demonstrated21 and positively charged molecules penetrate
the tissue faster than neutral molecules21.
With speciﬁc relevance to OA, HIU can potentially assist the
transport and delivery of TCs into and through cartilage. Using HIU,
three potential mechanisms have been identiﬁed to enhance the
delivery of large TCs. Particles or gas voids can be translated30e32,
the apparent diffusion rate of molecules may be enhanced33 or the
permeability of tissue may be increased34,35 [Table I, Figs. 2 and 3].
As a therapeutic adjunct, the potential ability of HIU to force large
molecules into cartilage is a promising approach to deliver then
entrap TCs to prolong their residence and therapeutic effects.ular cartilage is an avascular connective tissue a fewmillimeters in thickness that covers
oglycan and collagen content. The organization and orientation of collagen varies with
of systemic drug delivery; however, small particles (<10 nm in diameter) can penetrate
Table I
Ultrasound interactions with tissues. Contributions from a therapeutic perspective and highly simpliﬁed physical requirements that have mechanical or thermal relevance.
Included are examples from the literature that demonstrated ultrasoundetissue interaction in clinical or biological applications
HIU interactions with tissue
Ultrasound
interaction
Effect Requirements Examples
Radiation force  Push structures [Fig. 3(B)] or
particles [Fig. 3(C)]
 Large structure: Absorption or impedance
contrast118,133
 Small particle: Acoustic properties of particle
differ from surrounding medium118,134
 Acoustic Radiation Force Impulse
(ARFI) imaging133
 Moving contrast agent micro-bubbles30
 Deposit micro-particles on a vessel wall31
 Separate cells in a suspension135
 Separate nano-particles in a suspension32
 Thrombolysis136
Acoustic streaming  Push ﬂuid [Fig. 3(D)]  Fluid needs to absorb ultrasound energy137  Differentiate breast cysts from solid lesions138
 Fluid ﬂow in ovarian cysts139
Cavitation  Hammer [Fig. 3(E)], push ﬂuid
(jetting) [Fig. 7(C)]
 Ultrasound intensity exceeding threshold
for cavitation140
 Histotripsy75
 Lithotripsy49
 Phacoemulsiﬁcation94
 Gene transfection47
Acoustic shock  Tear, induce micro-crack [Fig. 3(F)]  Temporally highly localized ultrasound
intensity141
 Lithotripsy49
 Fatigue cracks to bone84
Thermal effect  Denaturate, ablate [Fig. 3(G)]  High ultrasound intensity and ultrasound
absorbing tissue47
 Thermally ablates tumors with HIFU in organs:
uterus, liver, prostate, brain and kidney47,48
 Palliate pain related to bone metastases50
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The biological effects of HIU have been known for over 80
years36 and have proven to be safe37 and efﬁcacious for medical
uses [Fig. 2]31,34,36,38e41. In medical applications, ultrasound is often
conceptualized as a non-invasive imaging modality for assessingFig. 2. Therapeutic HIU in action. A. Micro-bubble-assisted opening of blood brain barrier w
B. Low-frequency (20 kHz) permits delivery of agents into skin (red spots)39. CeD. Encapsula
wall (C, light microscopy) then a MHz HIU pulse released the agent locally adjacent to the wa
to shoot micron sized tungsten particles (upper arrow) into liver tissue (lower arrow)40. F. C
enables the controlled movement of drug-carrying vehicles along a desired path (green S-sh
into bovine cartilage (age < 3 years) then through cartilage and into subchondral bone after k
(H)34.
A reprinted from Liu et al.38. Copyright (2008), with permission from Elsevier; B reprinted fro
Reprinted, with permission, from Shortencarier et al.31; E reprinted from Menezes et al.40 (o
and Business Media; F reprinted with permission from Garcia-Gradilla et al.41. Copyright (201
Nieminen et al.34.fetal growth42, blood ﬂow (Doppler ultrasound)43,44 or elastic
properties of tissues (elastography)45,46. These applications typi-
cally use low-intensity ultrasound (LIU).
In biological applications, high-intensity ultrasound (HIU)
[Fig. 3] has been used to increase the permeability of the cell wall to
facilitate cell transfection47. Clinically, HIU has been used toith MHz focused HIU enabled the release of agents locally into the brain (red arrows)38.
ted contrast agents were ﬁrst pushed with acoustic radiation force against the far vessel
ll (D, epiﬂuorescent microscopy, bright red)31. E. Laser-induced shock-waves were used
ombination of MHz ultrasound, magnetic ﬁeld and miniscule magnetic drug containers
ape corresponds to the traveled path)41. G and H. Carbon nano-particles were delivered
Hz HIU exposure (G, dark contrast), whereas no particle delivery was seen without HIU
m Polat et al.39. Copyright (2011), with permission from Elsevier; C and D © (2004) IEEE.
riginally Fig. 8b, © Springer-Verlag 2008) with kind permission from Springer Science
3) American Chemical Society; G and H © (2012) IEEE. Reprinted, with permission, from
Fig. 3. Simpliﬁcation of HIU interactions with materials that can be harnessed to treat OA and cartilage injuries. Mechanical effects are shown in BeF and thermal effects in G. When
a traveling ultrasound pressure wave meets an interface between materials, part of the wave is reﬂected and part is transmitted (A, left). When this acoustic discontinuity is on the
order of one wavelength or less in diameter, the wave is scattered (A, right) rather than reﬂected. HIU can exert mechanical forces, i.e., push materials (B) or particles (C) as well as
cause ﬂuid streams via acoustic streaming (D). Fluid streams strong enough to break metal or tissue can be produced by ultrasonically collapsing cavitation micro-bubbles (E). In
addition, shock waves can induce large particle displacements that can tear materials (F). Focused ultrasound in particular can produce focal heating (G).
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pain50, to release drugs51 and to cut tissue52e54. Table I provides a
summary of ultrasoundetissue interactions in clinical or biological
applications.
As a surgical tool, the potential of HIU is relatively underutilized
compared to its application in other ﬁelds. There is a history
of industrial applications where materials have been modiﬁed
(mechanically or thermally) in a non-contact and controlled
manner using HIU. For many years HIU has been used e.g., to cut55,
homogenize56, mill57,58, drill59, translate60, tear61, heat56, weld62,
abrade63,64, polish65, soften66, or harden66 materials. Most impor-
tantly, this work has resulted in a broad and comprehensive
understanding of the physical principles of HIU [Fig. 3, Table I]
that is necessary for translation and development as a therapeutic
tool.
Therapeutically, the application of HIU in a minimally or non-
invasive manner is perhaps its most compelling attribute for
further clinical development [Fig. 2]. Small HIU-based tools
ranging from 3 mm (diameter of an ultrasound transducer)67 to as
small as 200 mm (diameter of a photo-acoustic optical ﬁber)68 can
enable operation within conﬁned regions like the joint space. HIU
applied using minimally invasive techniques may provide thera-
peutic effects by physically modifying articular cartilage and
subchondral bone. In such cases, HIU may generate micro-
channels in cartilage (as a form of micro-sized micro-fracture69)
or be used as a tool to non-thermally trim and modify tissues to
restore joint anatomy.Basic ultrasonic principles
Ultrasound is the high frequency coherent mechanical oscilla-
tory motion of atoms over the picometer to micrometer range.
Large amplitude atom motion is associated with high power or
intensity and is called HIU. Small amplitude atom motion is asso-
ciated with low power or intensity and is called LIU. While LIU and
HIU are related, they are different. A soft delineation between LIU
and HIU is HIU1W/cm2. Awave can be converted from LIU to HIU
by concentrating the same power onto a smaller area by focusing
the ultrasound beam [Fig. 3(G)]. This method of employing highly
focused ultrasound energy is called High-Intensity Focused Ultra-
sound (HIFU). HIFU is one application of HIU. In HIU, the atoms in an
attenuating medium no longer oscillate around their equilibrium
position like they do in LIU, but also have net movement along the
axis of sonication. This behavior induces a force that can press
structures [Fig. 3(B)], move particles within a medium [Fig. 3(C)]
and induce streams of ﬂow within a ﬂuid [Fig. 3(D)].
Ultrasonic mechanisms for the modiﬁcation of tissue structure
HIU is of particular interest in the treatment of OA because it has
the potential to act non-invasively on material through selected
mechanisms. HIU can “micro-machine” tissue in a non-touching
manner by either pushing [Fig. 3(B)e(E)], hammering [Fig. 3(E),
left], tearing [Fig. 3(F)] or heating [Fig. 3(G)] (Table I). Tearing arises
fromultrasound-induced shear forces70 or cavitation71, pushing can
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ultrasound arise from sound absorption73. In conjunction with
injected micro-bubbles, HIU can induce high speed ﬂuid micro-jets
[Fig. 3(E), left] that are strong enough to forge or break metal63,64.
Micro-jets present amethod to physicallymodify both hard and soft
tissue. Examples of conventional clinical HIU applications are: lith-
otripsy, i.e., the breaking of hard accretions such as kidney stones by
cavitation [Fig. 3(E)] or by acoustic shock [Fig. 3(F)]; histotripsy, i.e.,
fractionation of tissue by cavitation [Fig. 3(E)]; and thermal ablation
of tumor tissue by ultrasonic heating [Fig. 3(G), Table I]74e76.
Ultrasonic mechanisms for the delivery of TCs
There are four physical phenomena that have the potential to
facilitate local transport of TCs into articular cartilage and sub-
chondral bone using ultrasound. Radiation force can push particles
to move them in a speciﬁc direction [mechanism: Fig. 3(C)]. Micro-
streams can move ﬂuids in a speciﬁc direction. Local particles are
pulled along in the stream [mechanism: Fig. 3(D)]. Ultrasound can
also increase the apparent diffusion of a material by forming cavi-
tation jets of liquid that move particles along the jet direction
[mechanisms: Fig. 3(E)] and ﬁnally ultrasound can enhance tissue
permeability through cavitation. Cavitation creates defects in the
material where ﬂow is enhanced [mechanism: Fig. 3(E)].
Potential applications of HIU for the treatment of OA
In this section HIU methods are identiﬁed that could be used in
treatment of OA and cartilage injury as well as for the modiﬁcation
of pathological changes in joint anatomy. In the context of OA, this
review presents HIU as a paradigm-shifting approach enabling
minimally invasive delivery of TCs within cartilage and modiﬁca-
tion of osteochondral tissue at the nano- and micro-scale.
Current clinical approaches to manage OA
In simpliﬁed terms, clinical goals for the management of well-
established OA can be grouped into three general categories that
include the restoration of joint mobility, the inhibition of pain, and
the resolution of inﬂammation. The current standard of care for OA
is pain palliation22,27; however, surgical approaches such as tibial
osteotomy can restore sub-optimal joint loading conditions77 andFig. 4. Schematic presentation of cartilage structure during OA progression and cartilage i
composition as well as its mechanical properties. The ﬁnal stage of OA is characterized by
bone typically include ﬁssures and tears in cartilage and cracks to the subchondral bone. Dam
non-invasively treat cartilage and subchondral bone OA and injuries. These include machinin
damage (non-invasive or minimally invasive), inhibiting angiogenesis [Fig. 5(C), non-inva
Fig. 7(A)e(E), minimally invasive].weight loss can reduce demands placed on joints and symptoms of
OA78,79. Cartilage repair techniques called mosaicplasty and autol-
ogous chondrocyte transplantation have been applied to treat
traumatic injuries to cartilage, and micro-fracturing of subchondral
bone has been used to stimulate endogenous repair80. Cell-based
techniques that harvest, expand then implant autologous chon-
drocytes into articular defects have also shown promise for carti-
lage repair81.
HIU as a surgical tool
It has long been recognized that structural and compositional
changes to the joint and articular cartilage occur as a result of OA.
Changes in articular cartilage include collagen disruption, PG
depletion, and cell death2,82. Changes in subchondral bone include
sclerosis [thickening, Fig. 4] and changes in joint anatomy include
the formation and development of osteophytes2,14. Osteophytes
that restrict joint mobility are often removed surgically1,83.
A major and important advantage of HIFU is that it can
modify bone in a non-contact manner. HIFU can produce a
controlled focal point of applied energy that subjects the sur-
rounding material to high stress by the generation of shock
waves and cavitation49,84. Cavitation creates micro-jets of liquid
that has the potential to cut bone and perforate calciﬁed carti-
lage. In terms familiar to an orthopedic surgeon, the focal point
of applied ultrasound energy is equivalent to the cutting point of
a tool. As a cutting tool, HIFU is unique since unlike conventional
ultrasound knives with a vibrating blade52e54 the cutting point
of the tool does not need to be attached to a physical device. In
simpliﬁed terms, a surgeon could drill a hole without a drill or
drill bit and perhaps even without a line of sight to the location
of the hole.
Another signiﬁcant advantage is the potential to physically
modify bone or soft tissue without opening the joint space
[Fig. 4]67,68. A non-invasive surgical procedure on the knee would
minimize the risk of infection and reduce recovery time. However
promising, the ability to harness US as a surgical tool requires im-
aging and guidance and herein lies another advantage. Since US is
also an imaging modality, the same system can deliver therapy and
monitor treatment in real-time85,86. As a result, HIFU is inherently
amenable to computer guided surgery; i.e., data generated from 3D
scans of the joint can be used to guide and control machining ofnjuries. A. During the progression of OA changes occur in the cartilage structure and
bone-to-bone contact, pain, and joint disability. B. Injuries to cartilage and underlying
age to cartilage from injury can also lead to OA. C. Ultrasound provides the potential to
g of bone [Fig. 5(A) and (B), non-invasive or minimally invasive], the repair of soft tissue
sive or minimally invasive] and the release and transport of TCs [Fig. 6(A) and (B),
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treatment. Computer guided HIFU presents tangible potential
beneﬁts since an operation may be performed non-invasively, thus
obviating the need for instruments, a sterile ﬁeld and specialized
operating environments.
Speed and precision are other advantages of a HIFU based sur-
gical tool. Since the focal point of the transducer can be controlled
electronically the focal (cutting) point can be moved rapidly from
point to point within a ~10 ms time frame. The focal point can also
be accurately and rapidly moved across distances in the millimeter
to centimeter range without physically moving the transducer87,88.
Electronic control of the transducer focus also enables precise
movement of the focal point at a rate not practical with conven-
tional hand operated tools. Much like computer controlled
machining, the focal point can be rapidly moved across a 3D surface
to remove material in a variety of shapes and patterns. As a result,
tissues can be shaved, cut or perforated with both speed and
precision.
Modiﬁcation of bone
The perforation of subchondral bone is a clinical technique (also
known as Pridie drilling or micro-fracturing) that is used to stim-
ulate the repair of articular cartilage damaged by trauma89. The
insertion of a pointed instrument or drill through cartilage and
subchondral bone creates small holes a few mm in diameter that
communicate with themarrow space. It is believed that perforationFig. 5. Proposed non-pharmacological ultrasound techniques to modify articular cartilage a
by micro-machining using cavitation micro-jets. B. Micro-machining canals (e.g., shock wav
to migrate from bone into cartilage. C. Ultrasound can rupture tissue by collapsing gaseous
using HIU.aids the repair of AC defects by facilitating the migration of
mesenchymal stem cells to the damaged region1.
Unlike micro-fracturing, HIU has the potential to rapidly
generate micro-tunnels and micro-perforations inside subchondral
bone [Fig. 5(B)] (Table II) without penetrating the overlying AC. Like
micro-fracturing, an HIU tool could also perforate both cartilage
and subchondral bone. A HIU based micro-fracturing technique
presents distinct advantages over conventional surgical techniques.
Most importantly, HIFU has the potential to perforate tissue using
non-invasive or minimally invasive techniques67,68. Another
distinct advantage is the ability to produce defects of controlled
size, depth, and orientation.
An example of an HIU enhanced micro-fracture technique is the
generation of an array of micron-sized holes over a large area that
would be impractical (or not feasible) by manual drilling. The
generation of many sub-millimeter (even micrometer) defects may
reduce healing time, patient discomfort, scarring, and tissue dam-
age compared to conventional micro-fracturing. Ultrasonic micro-
fracturing of subchondral bone could be used to increase tissue
permeability and to enhance cellular cross-talk. Ultrasonic micro-
fracturing could also be used to enhance drug transport between
subchondral bone and cartilage [Fig. 5(A)] or to enhance stem cell
migration from bone to cartilage [Fig. 5(B)]. The development of
non-invasive image guided HIU machining of joint tissues with
micron level precision is a unique and promising near-term
advancement for improving the care of patients with OA.nd subchondral bone. A. Ultrasound can increase the permeability of subchondral bone
es or cavitation) into subchondral bone generate pathways for mesenchymal stem cells
bubbles. Systemic injection of micro-bubble encapsulated TCs enables their release of
Table II
Evaluation of ultrasound for the treatment of osteochondral tissue. The table summarizes key arguments for and against each technique, raises clinical questions, and summarizes the authors' opinion about which of the
techniques are clinically most relevant and which of the techniques are technically most feasible (+++ ¼ most, + ¼ least)
Potential of ultrasound to modify osteochondral tissue
Methods For Against Clinical aspects Clinical
importance
Technical
feasibility
Non-pharmacological Modiﬁcation
of bone
þ Ultrasound can crack bone84 by shock wave and titanium142,
which has a higher ultimate tensile strength than bone.
þ Ultrasound can modify material permeability (cavitation)143.
- Ultrasonic heating - may require
cooling and temperature monitoring.
- Ultrasound beam diffusion due to
bone heterogeneity.
 Subchondral bone perforation
may repair injured cartilage.
 Outcome may be OA stage dependent.
 Cyst removal may have clinical relevance.
+ ++
Modiﬁcation
of soft tissue
þ Ultrasound can thermally ablate connective tissue144 and
homogenize soft tissue by cavitation75,94.
- Not all tissues within the joint can
be accessed by ultrasound.
 If invasive, may have little advantages
relative to current surgical techniques.
+ +++
Inhibition of
angiogenesis
þ Ultrasound with micro-bubble contrast agent can induce
vessel rupture in vivo106,107.
þ Nerve growth related to angiogenesis induces pain in OA
and angiogenesis affects cartilage homeostasis95.
- Collapsing bubbles may induce
damage to neighboring tissue.
- Unknown whether inhibiting
vascularization is clinically
effective for OA management.
 Inhibiting angiogenesis can palliate
pain or restore homeostasis, although
not yet demonstrated95.
++ ++
Pharmacological Controlled
release of TCs
þ HIFU can release encapsulated drugs locally in vivo145,146. - Disease-modifying OA drugs
are still under development22.
 Disease-modifying drug for local
therapy yet to be discovered.
 TCs such as growth factors4,22,
anti-cytokines4,22,23, steroids24
and inhibitors4,22 have shown
disease-modifying potential22.
++ +++
Localized
delivery of TCs
into cartilage
and bone
þ Ultrasound can induce streams138, move particles147e150,
induce cavitation151,152 and elevate material permeability143.
þ In vivo feasibility demonstrated for skin39 and in vitro for
articular cartilage and subchondral bone34.
- Only one study demonstrating
ultrasound delivery in articular
cartilage or subchondral bone34.
- Forces pushing particles may
be small.
- To date, no disease-modifying
drugs are available.
+++ ++
General þ Ultrasound can propagate within the joint space153.
þ Ultrasound can access many joint areas non-invasively110.
- Bones may shadow non-invasive
ultrasound access to joint surfaces.
- Ultrasound may heat or induce
damage
- In a non-invasive application,
dermal tissue layers may interfere
with the ultrasound ﬁeld.
 The technique may require a
method to monitor presence
of cavitation.
 In case of risk to cause thermal
damage, thermal monitoring
with e.g., MRI may be required.
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Damage to the soft tissues of articulating joints includes
tears, tissue ﬂaps, and ﬁbrillation. Current treatment of meniscus or
cartilage damage includes the intra-articular removal of damaged
tissue with mechanical shavers90,91, saline jets92, and radio-
frequency tools90e92. Ultrasound has been used to remove tissue
by homogenization, debridement and/or thermal ablation75,93.
Examples of these are debridement of meniscus93, corneal phaco-
emulsiﬁcation94 and thermal ablation of tumors in the prostate,
breast, bone, brain, liver, and uterus47 (Table II). Histotripsy is
a technique where bubbles are collapsed and high speed ﬂuid
micro-jets disrupt tissue. In contrary to thermal HIFU approaches,
histotripsy is based on introducing shear forces exceeding
the fracture strength of the tissue at the site of the cavitation bubble
cloud75. An advanced HIU surgical tool could image, cut, shape
or ablate irregularities within the cartilage tissue using a non-
invasive approach while avoiding heating problems within the
tissue.
Inhibition of angiogenesis
Healthy AC does not contain blood vessels. However, in the
arthritic joint, blood vessels may form within the synovial capsule,
articular cartilage, and meniscus82,95,96. While angiogenesis is
usually part of the natural reparative process in many other tissues,
in articular cartilage and the meniscus it can be problematic95.
Vascular development is associated with elevated pain because
nerves accompany vessels. As a technique for pain management
arising from OA, HIU assisted denervation in the facet joint has
been applied clinically97,98. Angiogenesis is also associated with
synovial inﬂammation95,99,100, osteophyte formation100, and carti-
lage damage95,100. Both clinical and pre-clinical studies indicateFig. 6. Proposed ultrasound techniques to deliver TCs to articular cartilage and subchondr
systemic delivery (A, phase 1) of encapsulated TCs to cartilage. Breaking the encapsulated T
pressure or heat can be used to open up microcapsules containing TCs. Injection of encapsul
time (B, phase 2). Encapsulated TCs can also be released at a desired location, for example, th
(B, phase 3). Control of ultrasound beam geometry, frequency, sonication time and power, pa
delivery proﬁle.that the inhibition of angiogenesis can be an effective strategy to
treat OA95,101,102.
HIU has been used to staunch bleeding from injured
vessels103e105. In animal models vascular rupture has been induced
with HIU inmicro-vessels106 and, after injectingmicro-bubbles into
the blood circulation, in heart capillaries107. These results and
theory108 suggest that OA induced angiogenesis at the joint surface
could be controlled using HIU and micro-bubbles. To inhibit
vascular growth a method is proposed in which encapsulated TCs
(e.g., angiogenesis inhibitors109) are injected into an upstream
vessel and then angiogenetic cartilage is sonicated to locally release
TC to resolve angiogenesis [Fig. 5(C)] (Table II). Angiogenesis
management could be accessible non-invasively at marginal joint
surfaces; however, intra-articular approaches may be required (e.g.,
bones may shadow ultrasound propagation110).
Delivery of TCs by HIU
Controlled release of TCs
Controlled release systems reduce the requirement for continual
or repeated injection of TCs to the joint space. Beneﬁts of controlled
release systems include a reduction in the risk of infection,
increased patient compliance, reduced cost and care provider
effort. For small molecules with a short period of residence in
cartilage and a high rate of clearance from the joint space,
controlled release can increase their therapeutic potential28,29,111.
The controlled release of encapsulated TCs by ultrasound has been
applied to treat tumors in animal models112.
In this model, a highly soluble TC is temporarily rendered
insoluble by sequestration in a capsule. The capsule is susceptible to
HIU and exposure results in the release of the encapsulated TC.al bone. A. Angiogenesis, which often accompanies OA, can be used as a route for the
Cs using ultrasound enables localization and release of TCs (A, phase 2). B. Ultrasound
ated TCs (B, phase 1) into the joint space allows controlled release over long periods of
e site of degeneration or injury (B, phase 2), potentially followed by ultrasonic transport
rticle size, shape, and acoustic and mechanical hardness may allow shaping of a desired
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increases the agent concentration locally in the adjacent tissue31. A
distinct advantage of a HIU-based controlled release system is the
ability to physically move encapsulated TCs to the cartilage surface
prior to release31. The result is a potential increase in the local tissue
concentration and depth of delivery.
More speciﬁcally, encapsulated TCs are injected directly into the
joint space as shown in Fig. 6(B), phase 1. Extracorporeal applica-
tion of ultrasound enables spatial control over TC release by forcing
TCs to the cartilage surface [Fig. 6(A), phase 2]31. Once located at the
desired point of treatment, the release of TCs (pressure or tem-
perature sensitive microcapsules) is triggered by HIU, which en-
ables temporal control over TC release [Fig. 6(B), phase 2, left]
(Table II).
Another potential application is the local delivery of TC to sub-
chondral bone via direct injection of encapsulated TC in an up-
stream artery. Injected encapsulated TCs are transported by the
blood stream into the subchondral bone, where they are released
by ultrasound113 for the treatment of subchondral bone.Fig. 7. Schematic representation of ultrasonic delivery of TCs into articular cartilage. A and B
ultrasonic generated radiation forces. C. Fluid Streaming e active movement of liquid, i.e., a
Micro-jets e ultrasonic creation and collapse of air bubbles induce unidirectional high-s
diffusion-like force. E. Increased tissue permeability e ultrasound and cavitation-induced l
Self-assembly to sequentially transport (steps 1 and 2) a set of particles/molecules into the
allows the generation of larger molecules that have a greatly increased retention rate than
following examples are not in scale, but demonstrate the potential delivery mechanisms.Alternatively, TCs may also be transported to regions in AC where
new blood vessels have formed and then released by ultrasound114.
Localized delivery of TCs into cartilage and bone
Oral or systemic administration of TCs results in poor localiza-
tion and poor distribution within cartilage. The ability to directly
deliver TCs for highly localized treatment at a speciﬁc location of
cartilage and/or subchondral bone damage would provide thera-
peutic beneﬁt. Forcing particles or large molecules into cartilage
enhances the potential for prolonged therapeutic delivery as well
as direct targeting to the local tissue [Fig. 6(B), phase 3, Fig. 7,
Table II]. Four approaches have been identiﬁed to deliver TCs within
cartilage.
A promising strategy to enhance forced, localized delivery by
HIU is to link the TC to a carrier. In technical terms, a carrier serves
to increase the impedance contrast (much higher/lower) compared
to the surrounding medium. Carriers include inert gas bubbles like
argon, or inert hard and solid nano-particles (gold, aluminum ox-
ide, carbon nano-tubes, etc.).. Radiation force e particles (e.g., TCs or their carriers) can be pushed into cartilage by
coustic streaming, can carry small particles along the direction of ﬂuid movement. D.
peed liquid jets or multidirectional micro-streaming that provide a particle-pushing
iquid micro-jets can be used to damage tissue structures and increase permeability. F.
tissue then generate assembled structures (“ship-in-a-bottle approach”). Self-assembly
the smaller individual particles delivered. The structures of the cartilage matrix in the
H.J. Nieminen et al. / Osteoarthritis and Cartilage 22 (2014) 1784e17991794Using a forced delivery approach, particles can become trapped
within cartilage as they are subject to the same diffusion barriers
after ultrasonic application. A proof of principle study by our group
used HIU to force nano-sized particles to a depth of 3 mm though
AC and into subchondral bone34. TCs could also be injected into the
superﬁcial layer of cartilage with cavitation jets115,116, which have
been shown to penetrate cell walls. Other strategies include
delivering micro-particles with TCs into articular cartilage using
ultrasonic shock waves40.
Intelligent carriers that are activated and powered by ultra-
sound can also be used as delivery vehicles. Fig. 2(F) depicts micro-
or nano-sized ‘swimmers’, that only travel when sonicated117. These
nanoscale motors move deterministically, and have recently been
functionalized for drug delivery41. Such functionalized motors
could be directed into a desired location in cartilage.
An alternative approach to the forced delivery of a TC is to in-
crease the permeability of cartilage to the TC. Ultrasound can move
(vibrate) ﬁxed structures by radiation force118. Radiation force
could vibrate collagen and proteoglycans and produce secondary
ﬂuid currents around them. This would enhance the apparent
diffusion of particles and molecules into articular cartilage within
the ultrasound beam and improve particle transport from the
cartilage surface into the tissue.Self-assembly of TCs for localized retention
Particulate assembly (PA) is based upon the ability of ultrasound
to precipitate molecules dissolved in a solution119,120. The potential
beneﬁts of PA combine the ease of delivery of small particles with
the retention proﬁle of large particles. The potential effectiveness of
PA is based upon the preferential diffusion rate of small particles in
porous structures like cartilage. Once within the cartilage, the
particle diameter is increased by PA to approximate the pore
diameter. PA reduces the diffusion rate and effectively entraps the
larger molecule enabling prolonged therapeutic effect. Degradation
of the PA into smaller, functional therapeutic units is a form of
controlled release localizing and prolonging the therapeutic effects.
The ability to self-assemble molecules (“ship-in-a-bottle
approach”) using ultrasound is a similar approach based on theProblem Potential res
Excess heating a. Enhance
b. Reduce a
length/pu
c. Reduce u
d. Avoid exc
Insufﬁcient cavitation
Insufﬁcient elevation of cell membrane
permeability
a. Decrease
b. Increase a
- magnit
- pulse/b
- exposu
- increas
- or enha
c. Enhance
d. Introduce
Excess cavitation
Tissue tear
Excess elevation of cell membrane
permeability
a. Monitor f
b. Increase f
c. Decrease
- magnit
- pulse/b
- exposu
- or defo
Too weak acoustic micro-streaming,
streaming or radiation force effects
a. Increase f
b. Enhance
c. Increase a
d. Introducedelivery of small particles into cartilage that can be easily moved
within cartilage pores. Delivery of a second set of molecules that
can also be moved within cartilage pores follows. Once both mol-
ecules are inside cartilage, they undergo a spontaneous self-as-
sembly121,122 and form large particles which very slowly wash out
from the tissue [Fig. 7(F)].Mechano-biological effects of HIU
LIU has positive effects on cartilage regeneration: e.g., low in-
tensity pulsed ultrasound may induce migration of chondrogenic
progenitor cells to injury sites123, chondrogenic differentiation of
mesenchymal stem cells124 and enhance cartilage matrix produc-
tion125,126.While robust explanations for the cell stimulating effects
of ultrasound are lacking, thermal and non-thermal mechanisms
have been proposed47,127,128. The non-thermal bio-effects are
explained e.g., by increased nutrition due to streaming or shear
forces exerted on tissue matrix and cell walls due to acoustic
streaming, radiation force, bubbleeultrasound interactions or shear
waves such as Lamb waves127e129. Future studies will need to
demonstrate the potential of HIU to stimulate AC.
Like all interventional techniques, HIU also has potential
adverse effects47. To date, the biological effects of HIU in articular
cartilage have not been extensively studied. While studies
commonly report positive effects of ultrasound on articular carti-
lage, some studies have described negative effects. E.g., a recent
study demonstrated reduced proteoglycan and collagen type II
production by cartilage cells when excessive ultrasound intensities
(0.5e0.7 W/cm2) were applied daily for 1 week125. While no
observed structural damage to articular cartilage was reported in
another study130, shock waves may increase the permeability of
the chondrocyte cell wall and affect their viability130,131. Increased
cell wall permeability and damage to the tissue matrix can
be induced by cavitation34,132. Excessive heat results in protein
denaturation.
The following HIU principles can be used to achieve a thera-
peutic effect, while minimizing the risk for unwanted adverse
effects:olutions
tissue cooling
verage ultrasound power in the problem region (reduce amplitude or pulse/burst
lse repetition frequency (PRF), or modify the beam focusing)
ltrasound frequency to reduce absorption
ess exposure of bone-soft tissue interfaces to strong ultrasound
frequency (operate at kHz domain)
verage or momentary ultrasound power in the problem region, i.e., increase
ude of peak negative pressure amplitude
urst length
re time
e micro-streaming effects
nce focusing of the beam
streaming effect (see below)
cavitation seeds, e.g., micro-bubbles
or presence of cavitation/micro-bubbles
requency (operate at MHz domain)
average or momentary ultrasound power in the problem region, i.e., decrease
ude of peak negative pressure amplitude
urst length/PRF
re time
cus the beam
requency (operate at MHz domain)
focusing
verage ultrasound intensity
micro-bubbles to induce micro-streaming
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New therapeutic techniques to manage OA were presented
based on HIU interactions with cartilage and subchondral bone.
HIU associated therapeutic techniques offer promise to enhance the
delivery of TCs as well as to non-invasively modify tissues such as
cartilage, menisci and subchondral bone. This review focused on
HIU techniques that cannot be employed by conventional methods
and tools. A major strength of the proposed techniques is in the
capability of HIU to provide effect in a remote, non-invasive, and
non-contacting manner. However, as micro-scale therapy tasks
may require a free ultrasound propagation path (minimal inter-
ference from soft tissue layers and bone) some applications may
only be realized with an intra-articular device.
Clinically the most signiﬁcant of the proposed novel techniques
is localized drug delivery and release at the site of need. The most
ready-to-use device to permit localized delivery of TCs is non-
invasive image-guided (ultrasound or magnetic resonance imag-
ing) HIFU. Control of ultrasound beam geometry, frequency, soni-
cation time and power, particle size, shape, and hardnessmay allow
shaping a desired delivery outcome. It is worth noting that ultra-
sound may currently be the only physical approach that can
simultaneously provide imaging guidance, quantitative character-
ization of tissue (e.g., mechanical properties), and ability to perform
therapeutic tasks.
This work also shows the promise of inter-disciplinary collab-
oration between many ﬁelds. The concepts presented were
developed by identifying current limitations in clinical treatment
of OA, the unique properties of cartilage, the patho-physiology of
OA, and the potential application of ultrasound. The realization of
clinically applied technologies will likely result from a multi-
disciplinary collaboration between the ﬁelds of physics, biology,
biochemistry, chemistry, engineering, and orthopedics. The utility
of the proposed pharmacological techniques depends on avail-
ability of suitable TCs. Of course, it is possible and perhaps even
likely that these ultrasonic techniques may advance the develop-
ment of such TCs.Conclusions
This paper reviewed the potential utility of using HIU to perfo-
rate and micro-machine subchondral bone, to shape articular
cartilage, to carry out localized delivery and release of TCs and to
inhibit angiogenesis. This review ﬁnds ultrasound assisted localized
delivery of TCs to be the most prominent potential approach to
modify degenerated articular cartilage and subchondral bone.
Although a breakthrough in managing cartilage degeneration may
be based on pharmaco-therapeutic or tissue engineering ap-
proaches, it can be concluded that ultrasound could provide an
essential tool in treatments aiming to reverse or reduce the rate of
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